UNVC
Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes. The company offers 1 cc AD-syringe for aspirating and non-aspirating applications, which are used for dispensing dosages of allergy, immunization, and insulin medicines. It also manufactures and markets sliding sheath syringes that are designed to protect patients and healthcare workers from needle stick injuries; and bifurcated needle safety syringes, which are used in administering smallpox vaccines in response to bio-terrorist threats. Univec markets its auto-disable syringes and sliding sheath safety syringes to private hospitals, health facilities, and distributors in the United States, as well as to governments of developing countries. In addition, it assists pharmaceutical companies in marketing, fulfillment, and tracking drug samples via an online system connecting pharmacies and managed payment providers. The company was founded in 1992 and is based in Baltimore, Maryland.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | 0.00 | $19,250 | -$11,950 |
| 2025 Q4 | 0.00 | $17,500 | -$16M |
| 2025 Q3 | 0.00 | $33,389 | -$6,090 |
| 2025 Q2 | -0.00 | $17,875 | -$11,340 |
| 2025 Q1 | -0.00 | $16,250 | -$13,600 |
| 2024 Q4 | -0.00 | $14,160 | -$11,560 |
| 2024 Q3 | -0.00 | $5,400 | -$13,720 |
| 2024 Q2 | -0.00 | $6,608 | -$12,030 |